AEON Biopharma to Attend H.C. Wainwright 26th Annual Global Investment Conference 2024

IRVINE, Calif., Aug. 19, 2024 -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical entity, is pioneering the development of a botulinum toxin complex for various therapeutic applications. The company has announced that its President and Chief Executive Officer, Marc Forth, will deliver a corporate overview on Wednesday, September 11, 2024, at 1:30 PM ET during the H.C. Wainwright 26th Annual Global Investment Conference in New York, NY. Additionally, Mr. Forth will engage in one-on-one meetings with institutional investors who are attending the conference.

AEON Biopharma is dedicated to advancing its proprietary botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection, or ABP-450, for the treatment of serious medical conditions, primarily focusing on the neurosciences sector. Notably, ABP-450 is identical to the botulinum toxin complex marketed for cosmetic purposes under the name Jeuveau by Evolus. This product is produced by Daewoong in accordance with current Good Manufacturing Practice (cGMP) standards and has received approval from regulatory authorities such as the U.S. Food and Drug Administration, Health Canada, and the European Medicines Agency. Furthermore, ABP-450 has been approved as a biosimilar in Mexico and India.

AEON Biopharma holds exclusive rights for the development and distribution of ABP-450 for therapeutic purposes across the United States, Canada, the European Union, the United Kingdom, and several other international regions. The company boasts a management team with profound expertise in biopharmaceutical advancement and the commercialization of botulinum toxin products. 

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!